HTMwire assessment
TRIMEDX-native medical device cybersecurity platform that builds vulnerability management directly into clinical engineering workflows.
Built by TRIMEDX, so device security plugs straight into clinical engineering workflows instead of living in a separate IT silo.
HTMwire's independent read on the technology — not the vendor's marketing claim.
Marketed as a device cybersecurity platform; such tools commonly use ML-based anomaly detection, but we could not independently confirm Vigilor's specific technique.
Vigilor is owned by TRIMEDX, the clinical engineering services company, and is built natively on TRIMEDX data. Founded in 2023 and headquartered in Indianapolis, IN, it ties medical device cybersecurity directly into clinical engineering workflows.
Vigilor is used for medical device vulnerability management in HTM and clinical engineering teams. It surfaces device vulnerabilities, ties cyber risk to the CMMS, and helps prioritize remediation by clinical impact rather than treating device security as a separate IT problem.
Vigilor's differentiator is its native integration with TRIMEDX clinical engineering data, so device security plugs straight into clinical engineering workflows instead of living in a separate IT silo. That makes it well suited to HTM directors, hospital CIOs, and biomed managers at mid-size, large, and multi-site facilities.
Vigilor's specific AI use is unclear. It is marketed as a device cybersecurity platform, and such tools commonly use ML-based anomaly detection, but HTMwire could not independently confirm Vigilor's specific technique.
We cite a primary or named source for every claim on this page. How we evaluate →